Icon

ONEXTON (nda050819)- (3.75%;EQ 1.2% BASE)

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE BAUSCH
3.75%;EQ 1.2% BASE
Yes Yes
2029-Aug-05 Expired
None None
None No
ONEXTON is a combination of clindamycin phosphate (a lincosamide antibacterial) and benzoyl peroxide indicated for the topical treatment of acne vulgaris in patients 12 years or older.
2 1 1
Total Other Developers 3
Drugs with Suitability No
3.75%;EQ 1.2% BASE ** ** Up - 1
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.